A significant discovery in cancer investigation is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This vital cancer suppressor protein is frequently disabled in various types of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research